Bustamante J, Rimola A, Ventura P J, Navasa M, Cirera I, Reggiardo V, Rodés J
Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, University of Barcelona, Spain.
J Hepatol. 1999 May;30(5):890-5. doi: 10.1016/s0168-8278(99)80144-5.
There are numerous studies concerning the natural history and prognostic factors in cirrhosis, the results of which are useful in selecting liver transplant candidates. However, little attention has been paid to the prognostic significance of hepatic encephalopathy despite the high frequency of this complication.
We reviewed the charts of 111 cirrhotic patients who developed a first episode of acute hepatic encephalopathy to determine their survival probability and to identify prognostic factors.
During follow-up (12+/-17 months), 82 (74%) patients died. The survival probability was 42% at 1 year of follow-up and 23% at 3 years. With univariate analyses followed by a multivariate analysis, 7 out of 30 clinical and standard laboratory variables were significantly associated with poor prognosis: male sex, increased serum bilirubin, alkaline phosphatase, potassium and blood urea nitrogen, and decreased serum albumin and prothrombin activity. Patients were classified into two groups according to a prognostic index calculated from these 7 variables. Survival probability at 1 and 3 years was 73% and 38%, respectively, in patients with a low prognostic index, and 10% and 3% in patients with a high prognostic index.
Hepatic encephalopathy is associated with short survival in cirrhotic patients. Although these patients can be classified into several groups with a different prognosis, the survival probability in every group is lower than that currently expected after liver transplantation. Therefore, cirrhotic patients developing a first episode of acute hepatic encephalopathy should be considered as potential candidates for this therapeutic procedure.
关于肝硬化的自然病史和预后因素已有众多研究,其结果有助于筛选肝移植候选者。然而,尽管肝性脑病这一并发症发生率很高,但对其预后意义却鲜有关注。
我们回顾了111例首次发生急性肝性脑病的肝硬化患者的病历,以确定其生存概率并识别预后因素。
在随访期间(12±17个月),82例(74%)患者死亡。随访1年时生存概率为42%,3年时为23%。经过单因素分析后进行多因素分析,30项临床和标准实验室变量中有7项与预后不良显著相关:男性、血清胆红素升高、碱性磷酸酶升高、钾升高、血尿素氮升高,以及血清白蛋白降低和凝血酶原活性降低。根据由这7项变量计算出的预后指数将患者分为两组。预后指数低的患者1年和3年时的生存概率分别为73%和38%,预后指数高的患者则分别为10%和3%。
肝性脑病与肝硬化患者的短期生存相关。尽管这些患者可被分为预后不同的几组,但每组的生存概率均低于目前肝移植后的预期生存概率。因此,首次发生急性肝性脑病的肝硬化患者应被视为这一治疗手段的潜在候选者。